142 related articles for article (PubMed ID: 19440557)
1. Syk kinase inhibitors in allergic diseases.
Denyer J; Patel V
Drug News Perspect; 2009 Apr; 22(3):146-50. PubMed ID: 19440557
[TBL] [Abstract][Full Text] [Related]
2. Syk-kinase inhibition prevents mast cell activation in nasal polyps.
Patou J; Holtappels G; Affleck K; van Cauwenberge P; Bachert C
Rhinology; 2011 Mar; 49(1):100-6. PubMed ID: 21468383
[TBL] [Abstract][Full Text] [Related]
3. Identification of the Syk kinase inhibitor R112 by a human mast cell screen.
Rossi AB; Herlaar E; Braselmann S; Huynh S; Taylor V; Frances R; Issakani SD; Argade A; Singh R; Payan DG; Masuda ES
J Allergy Clin Immunol; 2006 Sep; 118(3):749-55. PubMed ID: 16950297
[TBL] [Abstract][Full Text] [Related]
4. Syk inhibitors as treatment for allergic rhinitis.
Masuda ES; Schmitz J
Pulm Pharmacol Ther; 2008; 21(3):461-7. PubMed ID: 17669674
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.
Moy LY; Jia Y; Caniga M; Lieber G; Gil M; Fernandez X; Sirkowski E; Miller R; Alexander JP; Lee HH; Shin JD; Ellis JM; Chen H; Wilhelm A; Yu H; Vincent S; Chapman RW; Kelly N; Hickey E; Abraham WM; Northrup A; Miller T; Houshyar H; Crackower MA
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1085-92. PubMed ID: 23889698
[TBL] [Abstract][Full Text] [Related]
6. Camellia japonica suppresses immunoglobulin E-mediated allergic response by the inhibition of Syk kinase activation in mast cells.
Lee JH; Kim JW; Ko NY; Mun SH; Kim DK; Kim JD; Kim HS; Lee KR; Kim YK; Radinger M; Her E; Choi WS
Clin Exp Allergy; 2008 May; 38(5):794-804. PubMed ID: 18261158
[TBL] [Abstract][Full Text] [Related]
7. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk.
Lee JH; Kim JW; Ko NY; Mun SH; Her E; Kim BK; Han JW; Lee HY; Beaven MA; Kim YM; Choi WS
J Allergy Clin Immunol; 2008 May; 121(5):1225-31. PubMed ID: 18394691
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase syk non-enzymatic inhibitors and potential anti-allergic drug-like compounds discovered by virtual and in vitro screening.
Villoutreix BO; Laconde G; Lagorce D; Martineau P; Miteva MA; Dariavach P
PLoS One; 2011; 6(6):e21117. PubMed ID: 21701581
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness.
Matsubara S; Li G; Takeda K; Loader JE; Pine P; Masuda ES; Miyahara N; Miyahara S; Lucas JJ; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2006 Jan; 173(1):56-63. PubMed ID: 16192454
[TBL] [Abstract][Full Text] [Related]
10. A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response.
Ramis I; Otal R; Carreño C; Domènech A; Eichhorn P; Orellana A; Maldonado M; De Alba J; Prats N; Fernández JC; Vidal B; Miralpeix M
Pharmacol Res; 2015 Sep; 99():116-24. PubMed ID: 26051661
[TBL] [Abstract][Full Text] [Related]
11. Syk inhibitors.
Chihara K; Kimura Y; Honjo C; Takeuchi K; Sada K
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(4):197-202. PubMed ID: 23994797
[TBL] [Abstract][Full Text] [Related]
12. Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases.
Bajpai M
IDrugs; 2009 Mar; 12(3):174-85. PubMed ID: 19333898
[TBL] [Abstract][Full Text] [Related]
13. Discovery and development of spleen tyrosine kinase (SYK) inhibitors.
Singh R; Masuda ES; Payan DG
J Med Chem; 2012 Apr; 55(8):3614-43. PubMed ID: 22257213
[No Abstract] [Full Text] [Related]
14. Inducing an anergic state in mast cells and basophils without secretion.
MacGlashan D; Undem BJ
J Allergy Clin Immunol; 2008 Jun; 121(6):1500-6, 1506.e1-4. PubMed ID: 18539198
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of switch kinase 'spleen tyrosine kinase' in inflammation and immune-mediated disorders: a review.
Kaur M; Singh M; Silakari O
Eur J Med Chem; 2013 Sep; 67():434-46. PubMed ID: 23917087
[TBL] [Abstract][Full Text] [Related]
16. Mast cell-mediated allergic response is suppressed by Sophorae flos: inhibition of SRC-family kinase.
Lee JH; Kim JW; Ko NY; Mun SH; Kim DK; Kim JD; Won HS; Shin HS; Kim HS; Her E; Kim YM; Choi WS
Exp Biol Med (Maywood); 2008 Oct; 233(10):1271-9. PubMed ID: 18641055
[TBL] [Abstract][Full Text] [Related]
17. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells.
Costello PS; Turner M; Walters AE; Cunningham CN; Bauer PH; Downward J; Tybulewicz VL
Oncogene; 1996 Dec; 13(12):2595-605. PubMed ID: 9000133
[TBL] [Abstract][Full Text] [Related]
18. A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally.
Mazuc E; Villoutreix BO; Malbec O; Roumier T; Fleury S; Leonetti JP; Dombrowicz D; Daëron M; Martineau P; Dariavach P
J Allergy Clin Immunol; 2008 Jul; 122(1):188-94, 194.e1-3. PubMed ID: 18539317
[TBL] [Abstract][Full Text] [Related]
19. Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK).
Farmer LJ; Bemis G; Britt SD; Cochran J; Connors M; Harrington EM; Hoock T; Markland W; Nanthakumar S; Taslimi P; Ter Haar E; Wang J; Zhaveri D; Salituro FG
Bioorg Med Chem Lett; 2008 Dec; 18(23):6231-5. PubMed ID: 18938080
[TBL] [Abstract][Full Text] [Related]
20. CD45 is essential for Fc epsilon RI signaling by ZAP70, but not Syk, in Syk-negative mast cells.
Zhang J; Siraganian RP
J Immunol; 1999 Sep; 163(5):2508-16. PubMed ID: 10452987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
